Angiotensin inhibition and malignancies: a review
- 2 April 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Human Hypertension
- Vol. 23 (10), 623-635
- https://doi.org/10.1038/jhh.2009.21
Abstract
No abstract availableThis publication has 63 references indexed in Scilit:
- Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatmentInternational Journal of Urology, 2008
- Regulation of prostate cancer cell growth and PSA expression by angiotensin II receptor blocker with peroxisome proliferator-activated receptor gamma ligand like actionThe Prostate, 2007
- Angiotensin I‐converting enzyme insertion‐related genotypes and allele are associated with higher susceptibility of endometriosis and leiomyomaMolecular Reproduction and Development, 2006
- Localisation of renin-angiotensin system (RAS) components in breastBritish Journal of Cancer, 2006
- Angiotensin-converting enzyme regulates bradykinin receptor gene expressionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Functional Expression of the Angiotensin II Type1 Receptor in Human Ovarian Carcinoma Cells and Its Blockade Therapy Resulting in Suppression of Tumor Invasion, Angiogenesis, and Peritoneal DisseminationClinical Cancer Research, 2005
- Multiple angiotensin receptor subtypes in normal and tumor astrocytes in vitroGlia, 2002
- Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasisBiochemical and Biophysical Research Communications, 2002
- Differences between Squamous Cell Carcinoma and Keratoacanthoma in Angiotensin Type-1 Receptor ExpressionThe American Journal of Pathology, 2001
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989